Updated on 2025/06/18

Information

 

写真a

 
OGATA HIROAKI
 
Organization
Kyushu University Hospital Respiratory medicine Assistant Professor
Title
Assistant Professor
Contact information
メールアドレス
Profile
医学部学生への臨床実習および教育（喘息・COPD、呼吸機能検査） 研修医への臨床教育と指導 病棟医員への臨床教育と指導 大学院生への研究指導

Research Areas

  • Life Science / Respiratory medicine

Degree

  • MD, PhD

Research History

  • Kyushu University Department of Respiratory Medicine Assistant Professor 

    2024.4 - Present

    　 More details

    Country：Japan

Education

  • Kyushu University   Graduate School of Medical Sciences   Department of Respiratory Medicine

    2015.4 - 2019.3

    　 More details

    Country：Japan

  • Kyushu University   Faculty of Medical Sciences   School of Medicine

    2005.4 - 2011.3

    　 More details

    Country：Japan

Research Interests・Research Keywords

  • Research theme： Clinical research in COPD

    Keyword： COPD

    Research period： 2024.4 - Present

Papers

  • Mortality and exacerbation risk according to GOLD and STAR severity stages of COPD: a 5-year multicenter prospective cohort study. Reviewed International journal

    Hiroaki Ogata, Kazuya Tsubouchi, Tomotsugu Takano, Katsuyuki Ichiki, Ryo Torii, Shohei Takata, Noriaki Nakagaki, Makoto Yoshida, Yasuhiko Kitasato, Kazunori Tobino, Eiji Harada, Hiroshi Wataya, Hiroshi Ishii, Takashige Maeyama, Masayuki Kawasaki, Masaki Fujita, Kazuhiro Yatera, Yoshiaki Zaizen, Yoichi Nakanishi, Isamu Okamoto

    Scientific reports   15 ( 1 )   19097 - 19097   2025.5

    　More details

    Authorship：Lead author,　Corresponding author   Language：English   Publishing type：Research paper (scientific journal)  

    The Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification, based on percent predicted forced expiratory volume in 1 s (ppFEV1), has been widely adopted for assessment of chronic obstructive pulmonary disease (COPD) severity. However, the STaging of Airflow obstruction by Ratio (STAR) system, based on the ratio of FEV1 to forced vital capacity, was recently proposed as an alternative classification. This study aimed to compare the prognostic performance of the GOLD and STAR classifications for prediction of mortality and exacerbation risk in individuals with COPD. This 5-year prospective, multicenter cohort study enrolled 370 individuals with COPD at 29 medical centers. All-cause mortality risk across GOLD and STAR stages was evaluated with Kaplan-Meier curves and Cox proportional hazards models. The risk of moderate to severe COPD exacerbations across GOLD and STAR stages was examined with cumulative incidence function (CIF) curves and Fine and Gray models. Both classification systems showed a significant association with mortality and exacerbation risk (P < 0.01 for trend). The GOLD classification provided a better separation of Kaplan-Meier and CIF curves for advanced stages, whereas the STAR classification showed a clearer distinction between stages I and II. These associations remained consistent after multivariable adjustments. The GOLD classification was superior for prediction of prognosis in advanced COPD, whereas the STAR classification provided better differentiation in early-stage disease. These findings highlight the complementary roles of the GOLD and STAR classifications in assessment of COPD severity.

    DOI： 10.1038/s41598-025-05033-w

    PubMed

  • Tezepelumab achieves improvement of severe uncontrolled asthma and rhinosinusitis: Case series. Reviewed International journal

    Shigesato Inoue, Hiroaki Ogata, Yoichi Dotake, Koichi Takagi, Ayaka Shiota, Yumiko Ishii, Kentaro Tanaka, Keiko Kan-O, Hiromasa Inoue

    The journal of allergy and clinical immunology. Global   4 ( 2 )   100448 - 100448   2025.5

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    Tezepelumab, a mAb targeting thymic stromal lymphopoietin (TSLP), reduces exacerbations in severe asthma. Four cases in which patients with severe asthma and chronic rhinosinusitis with nasal polyps showed improvements in both conditions after receiving tezepelumab treatment are presented.

    DOI： 10.1016/j.jacig.2025.100448

    PubMed

  • Preserved ratio impaired spirometry and severity of obstructive sleep apnea: An observational cross-sectional study Reviewed

    Hiroaki Ogata, Hiroshi Nakano, Toyoshi Yanagihara, Yuki Moriuchi, Aimi Enokizu-Ogawa, Akiko Ishimatsu, Junji Otsuka, Tomokazu Furukawa, Kazuhito Taguchi, Atsushi Moriwaki, Makoto Yoshida

    Respiratory Medicine   234   107806   2024.11   （ ISSN:0954-6111 eISSN:1532-3064 ）

    　More details

    Authorship：Lead author,　Corresponding author   Language：English   Publishing type：Research paper (scientific journal)   Publisher：Respiratory Medicine  

    Background and objective: Lung function abnormality of obstructive sleep apnea (OSA) has not been explored well. Preserved ratio impaired spirometry (PRISm) is known for its association with obesity and cardiovascular morbidity, which are also characteristic features of OSA. This study aims to investigate whether the prevalence of PRISm increases according to apnea–hypopnea index levels among subjects with OSA. Methods: Conducted as an observational cross-sectional study, the study included 372 patients ≥40 years of age with definitive diagnoses of OSA and pulmonary function assessment from 2000 to 2004. Study subjects were classified based on OSA severity (mild/moderate versus severe). The prevalence of PRISm was estimated and compared between mild/moderate and severe OSA groups. Results: The prevalence of PRISm was 9.4 % in study subjects, with a higher prevalence in the severe OSA group than the mild/moderate group (12.9 % and 6.2 %, respectively, P = 0.04). The positive association between severe OSA and PRISm remained robust after multivariable adjustment for age, gender, and obesity (multivariable-adjusted odds ratio 2.29 (95 % confidence intervals 1.08–4.86), P = 0.03). Conclusion: Severe OSA is an independent risk factor for PRISm, highlighting the need for comprehensive management of OSA that addresses the potential risk of PRISm.

    DOI： 10.1016/j.rmed.2024.107806

    Web of Science

    Scopus

    PubMed

  • The impact of COVID-19 on hay fever treatment in Japan: A retrospective cohort study based on the Japanese claims database Reviewed

    Yasutsugu Akasaki, Takenori Inomata, Masao Iwagami, Jaemyoung Sung, Ken Nagino, Takeya Adachi, Hideaki Morita, Mayumi Tamari, Keigo Kainuma, Keiko Kan-o, Hiroaki Ogata, Masafumi Sakashita, Masaki Futamura, Yosuke Kurashima, Saeko Nakajima, Katsunori Masaki, Yasushi Ogawa, Sakura Sato, Akihiro Miyagawa, Akie Midorikawa-Inomata, Keiichi Fujimoto, Yuichi Okumura, Kenta Fujio, Tianxiang Huang, Kunihiko Hirosawa, Yuki Morooka, Akira Murakami, Shintaro Nakao

    Clinical and Translational Allergy   14 ( 9 )   e12394   2024.9   （ ISSN:2045-7022 eISSN:2045-7022 ）

    　More details

    Language：English   Publishing type：Research paper (scientific journal)   Publisher：Clinical and Translational Allergy  

    Background: Hay fever (HF) presents with various symptoms, including allergic conjunctivitis and rhinitis, and requires cross-organ treatment. This study assessed the impact of the coronavirus disease 2019 (COVID-19) pandemic on HF treatment trends. Methods: This retrospective cohort study utilized data from the JMDC database collected between January 2018 and May 2021. Patients with HF were identified based on the relevant International Classification of Diseases 10th Revision diagnosis codes and the prescription of HF-related medications. The treatment approaches were compared during the cedar and cypress pollen allergy season (January to May in Japan) before and during the COVID-19 pandemic (2018 and 2019, and 2020 and 2021, respectively). Results: This study included 2,598,178 patients with HF. The numbers of prescribed HF-related claims in 2018, 2019, 2020, and 2021 were 3,332,854, 3,534,198, 2,774,380, and 2,786,681 times, respectively. Oral second-generation antihistamine prescriptions decreased by >10% from 2019 to 2020, with a <10% change in the subsequent year. Anti-allergic eye drop prescriptions also decreased by >10% from 2019 to 2020 but increased by >10% from 2020 to 2021. Compared with 2018, 2019, and 2020, the number of claims in the rhinitis symptoms dominant group was significantly decreased in 2021 (p < 0.001, all). In contrast, the number of claims in the eye symptoms dominant group and the rhinitis and eye symptoms dominant group increased in 2021 compared with that in 2018, 2019, and 2020 (p < 0.001, all). Conclusion: Changes in HF treatment and related outcomes could be attributed to lifestyle modifications resulting from the COVID-19 pandemic. Measures, such as limiting outdoor activities and adopting mask-wearing practices may have influenced HF symptoms, preventive behaviors, and the overall approach to treating HF.

    DOI： 10.1002/clt2.12394

    Web of Science

    Scopus

    PubMed

  • Amikacin liposome inhalation suspension in the real-world management of refractory mycobacterium avium complex pulmonary disease Reviewed International journal

    Toyoshi Yanagihara, Hiroaki Ogata, Asami Mori, Masako Kadowaki, Yuki Moriuchi, Akiko Ishimatsu, Junji Otsuka, Kazuhito Taguchi, Atushi Moriwaki, Makoto Yoshida

    Cureus   16 ( 3 )   e56622   2024.3

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

  • Acute exacerbation of idiopathic pulmonary fibrosis with concurrent cardiac amyloidosis: a technetium pyrophosphate study Reviewed International journal

    Toyoshi Yanagihara, Hikaru Hatashima, Hiroaki Ogata, Yuki Moriuchi, Akiko Ishimatsu, Junji Otsuka, Kazuhito Taguchi, Atushi Moriwaki, Makoto Yoshida

    Cureus   16 ( 3 )   2024.3

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

  • Insights from the trends of omalizumab and mepolizumab utilization in patients with asthma: a population-based cohort study using the National Database in Japan Reviewed International journal

    Keiko Kan-o, Tatsuya Noda, Hiroaki Ogata, Katsunori Masaki, Yuichi Nishioka, Tomoya Myojin, Takeya Adachi, Hideaki Morita, Tomoaki Imamura, Mayumi Tamari, Keigo Kainuma, on behalf of the ENGAGE NDB Task Force

    Respiratory Investigation   62 ( 1 )   113 - 120   2024.1

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

  • Impact of increased plasma levels of calreticulin on prognosis of patients with advanced lung cancer undergoing combination treatment of chemotherapy and immune checkpoint inhibitors Reviewed International journal

    Hirono Tsutsumi, Hiroyuki Inoue, Yoshimasa Shiraishi, Aiko Hirayama, Takayuki Nakanishi, Hiroyuki Ando, Maako Nakajima, Seiji Shinozaki, Hiroaki Ogata, Koji Okamura, Shinichi Kimura, Tomohiro Ogawa, Keiichi Ota, Yasuto Yoneshima, Kentaro Tanaka, Naoki Hamada, Isamu Okamoto, Eiji Iwama

    Lung Cancer   181   2023.7

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

  • The prognostic performance of lung diffusing capacity in preserved ratio impaired spirometry: an observational cohort study Reviewed International journal

    Hiroaki Ogata, Kachi Sha, Yasuaki Kotetsu, Aimi Enokizu-Ogawa, Katsuyuki Katahira, Akiko Ishimatsu, Kazuhito Taguchi, Atsushi Moriwaki, Makoto Yoshida

    International Journal of Chronic Obstructive Pulmonary Disease   17   2799   2022.10

    　More details

    Authorship：Lead author,　Corresponding author   Language：English   Publishing type：Research paper (scientific journal)  

  • The association between transfer coefficient of the lung and the risk of exacerbation in asthma-COPD overlap: an observational cohort study Reviewed International journal

    Hiroaki Ogata, Katsuyuki Katahira, Aimi Enokizu-Ogawa, Yujiro Jingushi, Akiko Ishimatsu, Kazuhito Taguchi, Hiroko Nogami, Hiroshi Aso, Atsushi Moriwaki, Makoto Yoshida

    BMC Pulmonary Medicine   22   2022.1

    　More details

    Authorship：Lead author,　Corresponding author   Language：English   Publishing type：Research paper (scientific journal)  

  • Impact of visceral fat on the prognosis of coronavirus disease 2019: an observational cohort study Reviewed International journal

    Hiroaki Ogata, Masahiro Mori, Yujiro Jingushi, Hiroshi Matsuzaki, Katsuyuki Katahira, Akiko Ishimatsu, Aimi Enokizu-Ogawa, Kazuhito Taguchi, Atsushi Moriwaki, Makoto Yoshida

    BMC Infectious Diseases   21   2021.12

    　More details

    Authorship：Lead author,　Corresponding author   Language：English   Publishing type：Research paper (scientific journal)  

  • Increased plasma levels of damage-associated molecular patterns during systemic anticancer therapy in patients with advanced lung cancer Reviewed International journal

    Hiroyuki Inoue, Hirono Tsutsumi, Kentaro Tanaka, Eiji Iwama, Yoshimasa Shiraishi, Aiko Hirayama, Takayuki Nakanishi, Hiroyuki Ando, Maako Nakajima, Seiji Shinozaki, Hiroaki Ogata, Kazuyasu Uryu, Koji Okamura, Shinichi Kimura, Tomohiro Ogawa, Keiichi Ota, Yasuto Yoneshima, Naoki Hamada, Yoichi Nakanishi, Isamu Okamoto

    Translational Lung Cancer Research   10 ( 6 )   2475 - 2486   2021.6

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

  • Association of serum antibodies against the Mycobacterium avium complex and hemoptysis: a cross-sectional study Reviewed International journal

    Hiroaki Ogata, Atsushi Moriwaki, Taisuke Nakagawa, Soichiro Sakoda, Akiko Ishimatsu, Kazuhito Taguchi, Hiroshi Aso, Hiroko Nogami, Masako Kadowaki, Yuko Tateshi, Makoto Yoshida

    BMC Infectious Diseases   21   2021.5

    　More details

    Authorship：Lead author,　Corresponding author   Language：English   Publishing type：Research paper (scientific journal)  

  • Airflow limitation and tongue microbiota in community-dwelling elderly individuals Reviewed International journal

    Toru Takeshita, Koichiro Matsumoto, Michiko Furuta, Satoru Fukuyama, Kenji Takeuchi, Hiroaki Ogata, Mikari Asakawa, Shinya Kageyama, Jun Hata, Toshiharu Ninomiya, Hiromasa Inoue, Yoshihisa Yamashita

    ERJ Open Research   7 ( 2 )   2021.5

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

  • Meteorological effects on severe hemoptysis: a hospital-based observational study Reviewed International journal

    Hiroaki Ogata, Koichiro Matsumoto, Seiji Shinozaki, Maki Hasegawa, Satoshi Nakamura, Shun Mizusaki, Tomoaki Takao, Keita Nakatomi, Nobutaka Nakashima, Kohei Takahashi, Hiroyasu Soeda, Kiyohiko Hanada, Hiroshi Koto

    Respiratory Investigation   57 ( 4 )   361 - 367   2019.7

    　More details

    Authorship：Lead author,　Corresponding author   Language：English   Publishing type：Research paper (scientific journal)  

  • Periodontitis is associated with chronic obstructive pulmonary disease Reviewed International journal

    Kenji Takeuchi, Koichiro Matsumoto, Michiko Furuta, Satoru Fukuyama, Toru Takeshita, Hiroaki Ogata, Shino Suma, Yukie Shibata, Yoshihiro Shimazaki, Jun Hata, Toshiharu Ninomiya, Yoichi Nakanishi, Hiromasa Inoue, Yoshihisa Yamashita

    Journal of Dental Research   98 ( 5 )   534 - 540   2019.5

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

  • Trends in the prevalence of airflow limitation in a general Japanese population: two serial cross-sectional surveys from the Hisayama Study Reviewed International journal

    Hiroaki Ogata, Yoichiro Hirakawa, Koichiro Matsumoto, Jun Hata, Daigo Yoshida, Satoru Fukuyama, Hiromasa Inoue, Takanari Kitazono, Toshiharu Ninomiya, Yoichi Nakanishi

    BMJ Open   9 ( 3 )   2019.3

    　More details

    Authorship：Lead author   Language：English   Publishing type：Research paper (scientific journal)  

  • Periodontal status and lung function decline in the community: the Hisayama study Reviewed International journal

    Kenji Takeuchi, Koichiro Matsumoto, Michiko Furuta, Satoru Fukuyama, Toru Takeshita, Hiroaki Ogata, Shino Suma, Yukie Shibata, Yoshihiro Shimazaki, Jun Hata, Toshiharu Ninomiya, Yoichi Nakanishi, Hiromasa Inoue, Yoshihisa Yamashita

    Scientific Reports   8   2018.9

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

  • Seasonal and meteorological impacts on primary spontaneous pneumothorax Reviewed International journal

    Hiroaki Ogata, Koichiro Matsumoto, Keita Nakatomi, Nobutaka Nakashima, Fumihiro Shoji, Hiroshi Koto

    Journal of Thoracic Disease   10 ( 7 )   3957 - 3964   2018.7

    　More details

    Authorship：Lead author,　Corresponding author   Language：English   Publishing type：Research paper (scientific journal)  

  • Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non-small cell lung cancer Reviewed International journal

    Kohei Otsubo, Kaname Nosaki, Chiyo K. Imamura, Hiroaki Ogata, Akitaka Fujita, Shinya Sakata, Fumihiko Hirai, Gouji Toyokawa, Eiji Iwama, Taishi Harada, Takashi Seto, Mitsuhiro Takenoyama, Takeshi Ozeki, Taisei Mushiroda, Mieko Inada, Junji Kishimoto, Kenji Tsuchihashi, Kentaro Suina, Osamu Nagano, Hideyuki Saya, Yoichi Nakanishi, Isamu Okamoto

    Cancer Science   108 ( 9 )   1843 - 1849   2017.9

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

▼display all

Presentations

  • 前向き長期追跡コホート研究における慢性閉塞性肺疾患の生命予後と吸入療法の関連：福岡肺の生活習慣病研究

    秋山元太，緒方大聡，髙野智嗣，坪内和哉，濱田直樹，一木克之，鳥井亮，矢寺和博，髙田昇平，中垣憲明，吉田誠，北里裕彦，飛野和則，藤田昌樹，財前圭晃，清見文明，德永章二，中西洋一，岡本勇．

    第65回日本呼吸器学会学術講演会  2025.4 

    　More details

    Event date： 2025.4

    Language：Japanese   Presentation type：Poster presentation  

    Venue：東京   Country：Japan  

  • 慢性閉塞性肺疾患における口腔由来細菌による肺常在微生物叢の変化の検討

    神尾敬子，影山伸哉，緒方大聡，城暁大，塩田彩佳，小川知洋，石井由美子，朝川美加李，竹下徹

    第65回日本呼吸器学会学術講演会  2025.4 

    　More details

    Event date： 2025.4

    Language：Japanese   Presentation type：Poster presentation  

    Venue：東京   Country：Japan  

  • オシメルチニブによる腎機能障害のリスク因子の検討

    宮﨑由依，岩間映二，緒方大聡，指宿立，柴原大典，大坪孝平，白石祥理，米嶋康臣，岡本勇．

    第65回日本呼吸器学会学術講演会  2025.4 

    　More details

    Event date： 2025.4

    Language：Japanese   Presentation type：Poster presentation  

    Venue：東京   Country：Japan  

  • 気道病変に限局した再発性多発軟骨炎の1例

    緒方大聡，萩原拓貴，松尾美央子，西村直矢，新納宏昭，岡本勇．

    第94回日本呼吸器学会九州支部春季学術講演会  2025.3 

    　More details

    Event date： 2025.3

    Language：Japanese   Presentation type：Oral presentation (general)  

    Venue：宮崎   Country：Japan  

  • テゼペルマブにより気管支喘息および好酸球性副鼻腔炎の改善を認めた一例

    萩原拓貴，緒方大聡，石井由美子，村上大輔，岡本勇．

    第93回日本呼吸器学会九州支部秋季学術講演会  2024.10 

    　More details

    Event date： 2024.10

    Language：Japanese   Presentation type：Oral presentation (general)  

    Venue：福岡   Country：Japan  

  • Preserved Ratio Impaired Spirometryおける肺拡散能の予後予測能力(The Prognostic Performance of Lung Diffusing Capacity in Preserved Ratio Impaired Spirometry)

    Ogata Hiroaki, Sha Kachi, Kotetsu Yasuaki, Enokizu-Ogawa Aimi, Katahira Katsuyuki, Ishimatsu Akiko, Taguchi Kazuhito, Moriwaki Atsushi, Yoshida Makoto

    日本呼吸器学会誌  2023.3  (一社)日本呼吸器学会

    　More details

    Language：English  

  • 喘息とCOPDのオーバーラップにおける肺のtransfer coefficientと増悪リスクとの関連性(The association between transfer coefficient of the lung and the risk of exacerbation in asthma-COPD overlap)

    Ogata Hiroaki, Katahira Katsuyuki, Enokizu-Ogawa Aimi, Jingushi Yujiro, Ishimatsu Akiko, Taguchi Kazuhito, Nogami Hiroko, Aso Hiroshi, Moriwaki Atsushi, Yoshida Makoto

    日本呼吸器学会誌  2022.4  (一社)日本呼吸器学会

    　More details

    Language：English  

  • 新型コロナウイルス感染症の予後に対し内臓脂肪が及ぼす影響(Impact of Visceral Fat on The Prognosis of Coronavirus Disease 2019)

    Ogata Hiroaki, Mori Masahiro, Jingushi Yujiro, Matsuzaki Hiroshi, Katahira Katsuyuki, Ishimatsu Akiko, Enokizu-Ogawa Aimi, Taguchi Kazuhito, Moriwaki Atsushi, Yoshida Makoto

    日本呼吸器学会誌  2022.4  (一社)日本呼吸器学会

    　More details

    Language：English  

  • Changes in the prevalence of airflow limitation in community-dwelling Japanese subjects：the Hisayama Study International conference

    Hiroaki Ogata, Yoichiro Hirakawa, Koichiro Matsumoto, Satoru Fukuyama, Hiromasa Inoue, Takanari Kitazono, Toshiharu Ninomiya, Yoichi Nakanishi

    American Thoracic Society International Conference 2018  2018.5 

    　More details

    Language：English  

  • Meteorological Impacts on Hemoptysis: A Hospital-Based Observational Study International conference

    Hiroaki Ogata, Koichiro Matsumoto, Seiji Shinozaki, Maki Hasegawa, Satoshi Nakamura, Shun Mizusaki, Tomoaki Takao, Keita Nakatomi, Nobutaka Nakashima, Kohei Takahashi, Hiroyasu Soeda, Kiyohiko Hanada, Hiroshi Koto

    American Thoracic Society International Conference 2019  2019.5 

    　More details

    Language：English  

  • 口腔衛生とCOPD

    緒方大聡

    第7回日本呼吸ケア・リハビリテーション学会九州沖縄支部学術集会  2020.2 

    　More details

    Language：Japanese  

  • 気管支喘息・COPDをどう治療していくのか：非薬物療法～運動療法・栄養管理を中心に～

    緒方大聡

    第85回日本呼吸器学会九州支部秋季学術講演会  2020.10 

    　More details

    Language：Japanese  

  • Association of serum antibodies against the Mycobacterium avium complex and hemoptysis International conference

    Hiroaki Ogata, Atsushi Moriwaki, Taisuke Nakagawa, Soichiro Sakoda, Akiko Ishimatsu, Kazuhito Taguchi, Hiroshi Aso, Hiroko Nogami, Masako Kadowaki, Makoto Yoshida

    the 25th congress of the Asian Pacific Society of Respirology  2021.11 

    　More details

    Language：English  

  • Impact of Visceral Fat on the Prognosis of Coronavirus Disease 2019

    Hiroaki Ogata, Masahiro Mori, Yujiro Jingushi, Hiroshi Matsuzaki, Katsuyuki Katahira, Akiko Ishimatsu, Aimi Enokizu-Ogawa, Kazuhito Taguchi, Atsushi Moriwaki, Makoto Yoshida

    第62回日本呼吸器学会学術講演会  2022.4 

    　More details

    Language：English  

  • The association between transfer coefficient of the lung and the risk of exacerbation in asthma-COPD overlap

    Hiroaki Ogata, Katsuyuki Katahira, Aimi Enokizu-Ogawa, Yujiro Jingushi, Akiko Ishimatsu, Kazuhito Taguchi, Hiroko Nogami, Hiroshi Aso, Atsushi Moriwaki, Makoto Yoshida

    第62回日本呼吸器学会学術講演会  2022.4 

    　More details

    Language：English  

  • The Prognostic Performance of Lung Diffusing Capacity in Preserved Ratio Impaired Spirometry

    Hiroaki Ogata, Kachi Sha, Yasuaki Kotetsu, Aimi Enokizu-Ogawa, Katsuyuki Katahira, Akiko Ishimatsu, Kazuhito Taguchi, Atsushi Moriwaki, Makoto Yoshida

    第63回日本呼吸器学会学術講演会  2023.4 

    　More details

    Language：English  

  • 難治性喘息のremissionを目指した生物学的製剤選択

    緒方大聡

    第92回日本呼吸器学会九州支部春季学術講演会  2024.3 

    　More details

    Language：Japanese  

▼display all

MISC

  • Impact of COVID-19 on care-seeking patterns for hay fever in Japan: A retrospective claims database cohort study

    Akasaki, Y; Iwagami, M; Sung, JMY; Nagino, K; Adachi, T; Morita, H; Tamari, M; Kainuma, K; Kan-o, K; Ogata, H; Sakashita, M; Futamura, M; Kurashima, Y; Nakajima, S; Masaki, K; Ogawa, Y; Sato, S; Miyagawa, A; Midorikawa-Inomata, A; Fujimoto, K; Okumura, Y; Fujio, K; Huang, TX; Hirosawa, K; Morooka, Y; Nakao, S; Murakami, A; Kobayashi, H; Inomata, T

    Allergy   79 ( 4 )   1056 - 1060   2024.4   （ ISSN:0105-4538 eISSN:1398-9995 ）

    　More details

    Language：English   Publishing type：Rapid communication, short report, research note, etc. (scientific journal)   Publisher：Allergy: European Journal of Allergy and Clinical Immunology  

    DOI： 10.1111/all.15947

    Web of Science

    Scopus

    PubMed

  • Novel FEV1/FVC-based diagnosis and severity classification of chronic obstructive pulmonary disease: how about FEV1 percent predicted basing?

    Hiroaki Ogata, Yasuyoshi Washio, Makoto Yoshida

    American Journal of Respiratory and Critical Care Medicine   209 ( 3 )   340 - 341   2024.2

    　More details

    Authorship：Lead author,　Corresponding author   Language：English   Publishing type：Rapid communication, short report, research note, etc. (scientific journal)  

  • COVID-19患者における強化呼吸補助療法の期間と長期呼吸不全のリスク(Duration of Intensive Respiratory Support and Risk of Long-term Respiratory Failure in Patients with COVID-19)

    Ogata Hiroaki, Jingushi Yujiro, Katahira Katsuyuki, Ishimatsu Akiko, Kotetsu Yasuaki, Sha Kachi, Enokizu-Ogawa Aimi, Taguchi Kazuhito, Moriwaki Atsushi, Yoshida Makoto

    Internal Medicine   61 ( 22 )   3467 - 3468   2022.11   （ ISSN:0918-2918 ）

    　More details

    Authorship：Lead author,　Corresponding author   Language：English   Publishing type：Rapid communication, short report, research note, etc. (scientific journal)   Publisher：(一社)日本内科学会  

Professional Memberships

  • American Thoracic Society

  • 日本アレルギー学会

  • 日本結核・非結核性抗酸菌症学会

  • 日本内科学会

  • 日本呼吸器内視鏡学会

  • 日本肺癌学会

  • 日本呼吸器学会

▼display all

Research Projects

  • 肺の生活習慣病の克服を目指した医療ネットワークの構築−喫煙関連呼吸器難病に対する前向きコホート研究−

    cohort study

    　 More details

    Authorship：Coinvestigator(s) 

    福岡県下29施設が参加し特発性間質性肺炎および慢性閉塞性肺疾患（COPD）を対象とした前向きコホート研究を行い、2013年9月より2016年4月の間に登録された1004例について5年間の追跡調査が終了した。COPDまたは肺気腫症例461例を対象に、最新のCOPDのリアルワールドデータとして生存期間・臨床背景・肺機能の経過・画像上の特徴について検討する。

  • 閉塞性肺疾患を有する患者と有しない患者由来の末梢気道細胞を用いた感染防御免疫 応答の解析

    clinical research

    　 More details

    Authorship：Coinvestigator(s) 

    気道のウイルス感染や細菌感染は気管支喘息やCOPDなどの閉塞性肺疾患の急性増悪の主たる原因であり、急性増悪を繰り返すことによりそれらの疾患の更なる病態悪化を招くことが知られている。ただし閉塞性肺疾患患者の気道局所における感染反復および急性増悪発症の機序は明らかでない。本研究では閉塞性肺疾患（気管支喘息あるいはCOPD）を有する患者と有しない患者由来の末梢気道細胞を採取し、培養条件下でウイルスや細菌に対する感染防御免疫応答の解析を行う。日常臨床として施行される気管支鏡検査の際に、少量の気道上皮細胞を採取培養し、ウイルスや細菌感染による免疫応答の変化を細胞レベルで比較検討する。

  • 閉塞性肺疾患を有する患者と有しない患者由来の唾液・舌苔・気管支被覆液を用いたマイクロバイオームの比較研究

    clinical research

    　 More details

    Authorship：Coinvestigator(s) 

    閉塞性肺疾患発症の主因はタバコ煙をはじめとした有害物質の長期吸入とされるが、罹患者の一部は非喫煙者であり、新規原因物質の特定が待たれている。近年、下気道・肺に微生物が常在することが明らかとなり、検出された菌種から口腔の常在微生物叢（マイクロバイオーム）が主要な供給源であることが指摘されている。我々は、口腔マイクロバイオームの量や質の悪化が、下気道における慢性炎症リスクに寄与しているとの仮説を立てた。本研究では、口腔マイクロバイオームの量や質の悪化が下気道・肺のマイクロバイオーム、肺機能などの検査所見や臨床症状へ及ぼす影響の検討を目的とする。閉塞性肺疾患を有する患者（患者群）と有しない患者（対照群）由来の唾液・舌苔および気管支被覆液を採取し、マイクロバイオームの性状について患者群間および群内での比較解析を行う。患者群および対照群のマイクロバイオームに影響を与える因子の同定・比較検討や、マイクロバイオームの差異が肺機能・胸部CT画像所見・臨床症状へ及ぼす影響の検討を行う。

Educational Activities

  • 呼吸器内科学の臨床診療（外来患者診療・入院患者診療・診療カンファレンス）
    炎症性気道疾患（喘息、COPD）の病態解明・新規治療の探索

Class subject

  • 臨床医学III-②　気管支喘息とCOPDの病態と治療

    2024.4 - 2024.9   First semester

  • 生理機能検査学I・II・III　呼吸機能検査と呼吸器疾患1

    2024.4 - 2024.9   First semester

  • 生理機能検査学I・II・III　呼吸機能検査と呼吸器疾患2

    2024.4 - 2024.9   First semester

Specialized clinical area

  • Biology / Medicine, Dentistry and Pharmacy / Internal Medicine / Respiratory Medicine

Clinician qualification

  • Certifying physician

    日本結核・非結核性抗酸菌症学会

  • Certifying physician

    The Japanese Society of Internal Medicine（JSIM）

  • Specialist

    The Japan Society for Respiratory Endoscopy（JSRE）

  • Preceptor

    The Japanese Respiratory Society

Year of medical license acquisition

  • 2011